by kztw547_admin_Skymab | Sep 16, 2024 | Non classé
September 24, 2024: Skymab is attending the 11th Annual HealthTech Investment Forum (#Sachs_HTIF) and the 24th Annual Biotech in Europe Forum (#Sachs_BEF) in Basel. We look forward to engaging with the investors community—let’s...
by kztw547_admin_Skymab | Sep 16, 2024 | Non classé
September 18-19, 2024: We’ll be at the North Life Sciences Days. Come discover our most recent innovations and explore partnership...
by kztw547_admin_Skymab | Sep 4, 2024 | Non classé
September 4-5, 2024: Meet the Skymab team at ADC Partnering in Boston, where we’ll be showcasing our cutting-edge work in ADCs. Don’t miss the chance to connect with...
by kztw547_admin_Skymab | Jun 20, 2024 | Non classé
June 20-21, 2024: Skymab will be attending the AIS Congress in Montpellier. Join us to learn more about our latest advancements in ADC...
by kztw547_admin_Skymab | Mar 12, 2024 | Non classé
March 12-15, 2024: The Skymab team will be at the World ADC Congress in London. We’re eager to connect with industry leaders—come meet...
by kztw547_admin_Skymab | Feb 16, 2024 | Non classé
We’re thrilled to announce that Skymab has been awarded a Pfizer Golden Ticket at Paris BioLabs! This prestigious recognition underscores our innovative work in advancing antibody-drug conjugates (ADCs). We’re excited to leverage this opportunity to further accelerate...
Recent Comments